Robyn Shaw Promoted to Chief Operating Officer at Noble Life Sciences
August 7, 2024
| BioBuzz’s mission is simple: to be more connected. Our regionally-focused storytelling, programs, events and experiences connect, amplify and create impact across the life science workforce in growing biohubs. Submit your People On The Move (free and ongoing) to showcase your company’s growth by promoting your new hires and recent promotions. |
Robyn Shaw has been appointed as the Chief Operating Officer at Noble Life Sciences (NLS). With over 20 years of experience in the contract research industry, Shaw brings a wealth of knowledge and expertise to her new role. Her extensive background in research toxicology, immunology, and infectious diseases, coupled with her experience in preclinical studies, positions her to lead NLS to new heights.
About Robyn Shaw
Robyn Shaw holds a bachelor’s degree in Biology from Washington College and a master’s degree in Biotechnology from Johns Hopkins University. She began her career at Spring Valley Laboratories (SVL) as a Study Director, where she managed both GLP and non-GLP studies. Following SVL’s acquisition by NLS, Shaw continued to excel, taking on roles that included serving on the Institutional Animal Care and Use Committee (IACUC), where she currently chairs the committee.
In her previous role as Director of Preclinical Services at SVL, Shaw gained significant experience in overseeing preclinical studies in various toxicology environments. Now, as Chief Operating Officer at NLS, she is responsible for the overall facility operations, including scheduling research procedures, managing vivarium facility staff, and identifying areas for quality and operational improvements.
Shaw has been with NLS since 2014, and she appreciates the collaborative environment and the opportunity to work on diverse projects, such as GLP vaccine toxicology studies. She values the challenges and rewards of providing reliable services to clients and presenting their studies to the FDA.
About Noble Life Sciences
Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Our services are designed to help you advance from concept to clinic faster and more efficiently.
Noble’s state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble’s vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
